Global Syndromic Multiplex Panels Market Set for Rapid Expansion, Reveals New 2024-2028 Sector Forecast
Dublin, March 12, 2024 (GLOBE NEWSWIRE) -- The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028" report has been added to ResearchAndMarkets.com's offering.
The latest report on Syndromic Multiplex Diagnostics has been added to our comprehensive suite of market analysis offerings, elucidating critical paths in infectious disease diagnostics. Titled "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI, etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028," the publication offers an in-depth exploration of the projected market expansion over the next five years.
The emergence of advanced diagnostic options is changing the current landscape of infectious disease detection and management. This report provides a meticulous overview of these shifts and their implications on future market growth. The integration of Point of Care Testing (POCT) and Molecular Diagnostics forms a significant trend, demonstrating potential to revolutionize standard testing protocols while optimizing healthcare expenditures.
Syndromic testing: A game-changer in the infectious disease diagnostics industry, this approach adopts multiplex panels designed to detect multiple pathogens in a single assay. The report discusses whether such advancements might render targeted tests for specific pathogens obsolete or transform the role of medical diagnostics altogether.
The Market Outlook
Detailed forecasts reveal the market potential for Syndromic Multiplex Diagnostics, categorized by syndrome, location of testing, product types, and country-specific data.
The report examines the propensity for these diagnostics to shift from clinical environments to point-of-care settings, including physician's offices and potentially patient homes.
Insight is provided on how these technologies could possibly displace most frontline test protocols and save money simultaneously.
Researchers, industry stakeholders, and healthcare professionals will find this report a pivotal resource for understanding the current state of Syndromic Multiplex Diagnostics and anticipating its future trajectory. The insights provided are expected to be instrumental in strategic decision-making for those within the infectious disease diagnostics field. The comprehensive data included not only paves the way for informed forecasting but also highlights the impact of POCT and Molecular Diagnostics on the overall healthcare industry. For all inquiries regarding this latest market forecast, further information is available to support your industry analysis requirements and strategic planning.
Key Topics Covered
Market Guides
Introduction and Market Definition
Infectious Disease
Industry Overview
Market Trends
Syndromic Testing Recent Developments
Profiles of Key Syndromic Testing Companies
The Global Market for Syndromic Multiplex Diagnostics
Global Syndromic Multiplex Markets - By Syndrome
Global MDx Infectious Disease Markets - by Place
Global MDx Infectious Disease Markets - by Product
Appendices
Companies Mentioned
Abacus Diagnostica
Abbott Laboratories
Accelerate Diagnostics
Ador Diagnostics
ADT Biotech
Akonni Biosystems
Alveo Technologies
Antelope Dx
Applied BioCode
Aureum Diagnostics
Aus Diagnostics
Baebies
Beckman Coulter Diagnostics
Becton, Dickinson and Company
Binx Health
Bio-Rad Laboratories, Inc
Biocartis
BioFire Diagnostics (bioMérieux)
bioMérieux Diagnostics
Biosystems
Bosch Healthcare Solutions GmbH
Cepheid (Danaher)
Credo Diagnostics Biomedical
Cue Health
Curetis N.V./Curetis GmbH
Detect
Diagenode Diagnostics
Diasorin S.p.A.
Domus Diagnostics
Enzo Biochem
Eurofins Scientific
Fluxergy
Fusion Genomics.
Genetic Signatures
GenMark Dx (Roche)
Grip Molecular Technologies
Hibergene Diagnostics
Hologic
Immunexpress
Inflammatix
Invetech
Janssen Diagnostics
Karius
Lexagene
LightDeck Diagnostics
Lucira Health
Luminex Corp (DiaSorin)
Maxim Biomedical
Meridian Bioscience
Mesa Biotech (Thermo Fisher)
MicroGem
Millipore Sigma
Minute Molecular
Mobidiag (Hologic)
Molbio Diagnostics
Nanomix
Novel Microdevices
OnsiteGene
Operon
Oxford Nanopore Technologies
Panagene
Perkin Elmer
Primerdesign (Novacyt)
Prominex
Proof Diagnostics
Qiagen
QuantuMDx
QuidelOrtho
Roche Molecular Diagnostics
Saw Diagnostics
Scope Fluidics
Seegene
Siemens Healthineers
Sona Nanotech
SpeeDx
Talis Biomedical
Thermo Fisher Scientific Inc.
Vela Diagnostics
Veramarx
Visby Medical
XCR Diagnostics
For more information about this report visit https://www.researchandmarkets.com/r/42k7sh
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900